Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.
Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
Artif Organs. 2023 Jul;47(7):1122-1132. doi: 10.1111/aor.14523. Epub 2023 Apr 4.
Pulsatile-flow veno-arterial extracorporeal membrane oxygenation (V-A ECMO) has shown encouraging results for microcirculation resuscitation and left ventricle unloading in patients with refractory cardiogenic shock. We aimed to comprehensively assess different V-A ECMO parameters and their contribution to hemodynamic energy production and transfer through the device circuit.
We used the i-cor® ECMO circuit, which composed of Deltastream DP3 diagonal pump and i-cor® console (Xenios AG), the Hilite 7000 membrane oxygenator (Xenios AG), venous and arterial tubing and a 1 L soft venous pseudo-patient reservoir. Four different arterial cannulae (Biomedicus 15 and 17 Fr, Maquet 15 and 17 Fr) were used. For each cannula, 192 different pulsatile modes were investigated by adjusting flow rate, systole/diastole ratio, pulsatile amplitudes and frequency, yielding 784 unique conditions. A dSpace data acquisition system was used to collect flow and pressure data.
Increasing flow rates and pulsatile amplitudes were associated with significantly higher hemodynamic energy production (both p < 0.001), while no significant associations were seen while adjusting systole-to-diastole ratio (p = 0.73) or pulsing frequency (p = 0.99). Arterial cannula represents the highest resistance to hemodynamic energy transfer with 32%-59% of total hemodynamic energy generated being lost within, depending on pulsatile flow settings used.
Herein, we presented the first study to compare hemodynamic energy production with all pulsatile ECLS pump settings and their combinations and widely used yet previously unexamined four different arterial ECMO cannula. Only increased flow rate and amplitude increase hemodynamic energy production as single factors, whilst other factors are relevant when combined.
脉动血流静脉-动脉体外膜肺氧合(V-A ECMO)已显示出在难治性心源性休克患者中对微循环复苏和左心室卸载的令人鼓舞的结果。我们旨在全面评估不同的 V-A ECMO 参数及其对通过设备回路进行的血液动力学能量产生和传递的贡献。
我们使用了 i-cor® ECMO 回路,该回路由 Deltastream DP3 对角泵和 i-cor®控制台(Xenios AG)、Hilite 7000 膜式氧合器(Xenios AG)、静脉和动脉管以及 1 L 软静脉假性患者储液器组成。使用了四种不同的动脉插管(Biomedicus 15 和 17 Fr、Maquet 15 和 17 Fr)。对于每个插管,通过调整流量、收缩/舒张比、脉动幅度和频率,研究了 192 种不同的脉动模式,产生了 784 种独特的条件。使用 dSpace 数据采集系统收集流量和压力数据。
增加流量和脉动幅度与更高的血液动力学能量产生显著相关(均 p<0.001),而调整收缩/舒张比(p=0.73)或脉动频率(p=0.99)时则没有显著关联。动脉插管代表对血液动力学能量传递的最高阻力,根据使用的脉动流量设置,总血液动力学能量的 32%-59%会在其中损失。
本文首次比较了所有脉动 ECLS 泵设置及其组合以及广泛使用但以前未检查的四种不同动脉 ECMO 插管的血液动力学能量产生,并进行了研究。只有增加流量和幅度才能作为单一因素增加血液动力学能量产生,而其他因素在组合时则相关。